Author:
Zein-Sabatto Ahbid,Bico Adrian,Woo Madison,Fariha Ramisa,Ip Blanche,Hoffman-Kim Diane,Morgan Jeffrey,Lee Jonghwan
Abstract
Functional precision medicine directly screens chemotherapeutics in patient tissue; however, technical challenges limit its clinical feasibility. OCT viability imaging in 3D microtissues overcomes these limitations and has shown tissue and treatment specific changes in viability.